# Sequential targeting in multiple myeloma: talquetamab, a GPRC5D bispecific antibody, as a bridge to BCMA CAR-T therapy

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/sequential-targeting-in-multiple-myeloma-talquetamab-a-gprc5d-bispecific/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Binod Dhakal,Othman Salim Akhtar,David Fandrei,Alexandria Jensen,Rahul Banerjee,Darren Pan,Shambavi Richard,Reed Friend,Matthew J. Rees,Patrick Costello,Mariola Alejandra Vazquez Martinez,Oren Pasvolsky,Charlotte B Wagner,James A. Davis,Omar Castañeda Puglianini,Ran Reshef,Aimaz Afrough,Danai Dima,Manisha Bhutani,Omar Nadeem,Ricardo Parrondo,Ciara L. Freeman,Lekha Mikkilineni,Shahzad Raza,Larry D. Anderson,Prashant Kapoor,Hitomi Hosoya,Saurabh Chhabra,Ariel Grajales‐Cruz,Mahmoud Gaballa,Shonali Midha,Melissa Alsina,Douglas W. Sborov,Krina K. Patel,Yi Lin,Christopher J. Ferreri,Nico Gagelmann,Anupama Kumar,Doris K. Hansen,Andrew J. Cowan,Luciano J. Costa,Maximilian Merz,Surbhi Sidana |
| Citations | 30 |
| DOI | 10.1182/blood.2025029773 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W4412836268 |
| PMID | 40749169 |
| Type | article |
| Year | 2025 |

## Paper authors

- [Yi Lin](https://scholariq.org/researchers/yi-lin/)

## Paper journal

- [Blood](https://scholariq.org/journals/blood/)

## Paper primary topic

- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)

## Paper topics

- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Multiple Myeloma Research and Treatments](https://scholariq.org/topics/multiple-myeloma-research-and-treatments/)
- [Insect Resistance and Genetics](https://scholariq.org/topics/insect-resistance-and-genetics/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.